Quantcast

Latest Prostate cancer Stories

2014-05-22 16:27:00

Milestone System to Handle Full Patient Load for New, Integrated Cancer Center in Scottsdale, Arizona SUNNYVALE, Calif., May 22, 2014 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the installation of its 500(th )TomoTherapy® System at the grand opening of Palo Verde Cancer Center - Scottsdale in Scottsdale, Ariz. The System, a TomoHDA(TM) model, is the only radiation therapy device at the new center, which also offers medical oncology services. The center's...

2014-05-21 12:04:38

University of Melbourne Researchers have identified nine simple questions that can be used to identify people who may be at increased risk of various cancers, heart disease and diabetes because of their family history of these conditions. The family history screening questionnaire can be used to provide insight into people’s susceptibility to breast, ovarian, bowel and prostate cancer, melanoma, ischaemic heart disease and type 2 diabetes. These findings will lead to greater...

2014-05-20 16:27:05

New Analysis Suggests Oncotype DX Predicts Recurrence Risk After Prostatectomy Regardless of Post-Surgery Treatment REDWOOD CITY, Calif., May 20, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today presented positive results reinforcing the robustness of the Oncotype DX(®) prostate cancer test's development as a predictor of prostate cancer aggressiveness. A sub-analysis of a large Oncotype DX Genomic Prostate Score (GPS) development study, presented at the American...

2014-05-20 16:26:25

Two Studies Presented at 2014 AUA Annual Meeting SAN DIEGO, May 20, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced the presentation of data showing that its Decipher® Prostate Cancer Classifier, a genomic test capable of predicting metastatic prostate cancer, was able to identify patients that may be spared of radiation therapy after prostate surgery who would have been otherwise classified as high risk based on current clinical practice guidelines. In a separate study,...

2014-05-20 12:33:00

As FDA Process Proceeds, Kanzius Cancer Research Foundation Realizes Ultimate Goal ERIE, Pa., May 20, 2014 /PRNewswire/ -- Before losing his bout with leukemia in 2009, John Kanzius vowed to find "a better way" to treat cancer. Today, more than four decades after the US declared "war on cancer," we are one step closer to a world where cancer is treated with no side effects. In the coming weeks, a research team led by Drs. Steven Curley, Stuart Corr, and Rita Serda will submit an...

2014-05-20 08:34:45

WORCESTER, Mass. and TORONTO, May 20, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced two upcoming presentations demonstrating that certain patients with early stage breast cancer who receive AE37 may benefit in terms of reduced risk of relapse. The AE37 breast cancer vaccine is being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com). The presentations will be made at the 50(th)...

2014-05-20 08:34:18

New studies highlight impact of certain conditions on prostate cancer severity, role diet may play in etiology ORLANDO, Fla., May 20, 2014 /PRNewswire-USNewswire/ -- Three new studies featuring the impact of dietary and lifestyle factors on prostate cancer will be presented during the 109(th) Annual Scientific Meeting of the American Urological Association (AUA). The research will be highlighted by study authors during a special press conference at the Orange County Convention Center...

2014-05-19 23:02:53

Transparency Market Research Report Added "Adjuvants Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018" to its database. Browse Full Report: http://www.transparencymarketresearch.com/adjuvants-market.html. Albany, New York, USA (PRWEB) May 19, 2014 Adjuvant oncology treatment comprises of a class of cancer therapeutics which is followed after primary cancer treatment, to minimize the risk of reoccurrence of cancer. The major forms of...

2014-05-19 10:21:58

University of Cincinnati Academic Health Center About one in seven men will develop prostate cancer over the course of a lifetime, and about one in 36 men will die from it. This is why findings by Cincinnati Cancer Center researchers, showing that a tumor suppressive microRNA, when activated by an anti-estrogen drug, could contribute to development of future targeted therapies, are important. These findings are published in the May 16, 2014 edition of the journal PLOS ONE....

2014-05-18 12:20:20

ORLANDO, Fla., May 18, 2014 /PRNewswire-USNewswire/ -- With an accuracy rating of 98 percent, specially-trained dogs were able to smell volatile organic compounds (VOCs) released into urine by prostate tumors, setting the stage for a potentially new means of early prostate cancer detection, according to a new study at the 109(th) Annual Scientific Meeting of the American Urological Association (AUA). The study will be presented to the media during a special press conference on Sunday, May 18...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related